Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 10:49 AM UTC
| NCT Number | NCT06568939 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 150 participants |
| Active Locations | 40 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | October 5, 2026 (2 weeks ago) |
As of October 19, 2026: Clinical trial NCT06568939 is currently recruiting participants. This phase2 study for non-small cell lung cancer is actively seeking new participants at 40 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06568939 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06568939 was last updated 2 weeks ago (October 5, 2026). HelloStudys verifies this status automatically.